ODDB.org: Open Drug Database

Teva Pharma AG - Irinotecan-Teva liquid 500 mg/25 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	59217	Sequence	03
Product name	Irinotecan-Teva liquid 500 mg/25 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01CE02	ATC-Description
Introduction of Sequence	21.05.2010

Composition

irinotecani hydrochloridum trihydricum 500 mg, sorbitolum 1125 mg, acidum (S)-lacticum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 25 ml corresp. natrium 2.156 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	500mg / 25ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	500 mg

Inactive agents	Dose



Sorbitol	1125mg / 25ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
008		357.73	405.70	A	SL	No

2025	©ywesee GmbH